Browse by article | Browse by volume |
Heroin Addiction and Related Clinical Problems: 2024, 26, 1
Penghui Cao, Qiaofang Huang, Nannan Pan, Huaxin Li, Daoyi Feng, and Ziyan Fang
Digital Object Identifier:
https://doi.org/10.62401/2531-4122-2024-1
Summary: Background A proportion of MMT patients suffer from anxiety and depression after withdrawing from methadone treatment, which may have a negative impact on their physical and mental health and social recovery and even increase their risk of relapse. Aim: This study investigates the effect of life-related factors on MMT patients' emotional status and quality of life after withdrawal from methadone maintenance treatment. Method Fifty-eight MMT patients who had withdrawn from methadone maintenance therapy were included in this study and followed up for one year. The socio-demographic, previous heroin use status and previous methadone therapy status were documented at the first-time interview. Anxiety level was evaluated by the Beck Anxiety Inventory (BAI). Depression level was assessed by Beck Depression inventory-13 (BDI-13). The life quality of all participants was evaluated by The Quality of Life-Drug Addiction (QOL-DA). Data on life-related factors, anxiety status, depression status and quality of life were collected from all participants at both the first-time interview and the follow-up interview. Results. At the first interview, 24.1% of participants had varying degrees of depression, and 19% had varying degrees of anxiety. At the follow-up interview, one year later, as their marital status, living status and income status changed in a positive direction, their anxiety and depression had improved, and their life quality had also improved. Conclusions Changes in life-related factors in a positive order improve MMT patients’ emotional status and quality of life after withdrawal from methadone therapy.
Keywords: Methadone maintenance therapy; Life-related factors; Emotional problems; Life quality
EUROPAD - European Opiate Addiction Treatment Association Brussels, Belgium, EU P. IVA 01681650469 – Codice Fiscale 94002580465 Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org |